Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia

Leukemia. 2014 Feb;28(2):417-9. doi: 10.1038/leu.2013.271. Epub 2013 Sep 19.

Authors

D Bellanger¹, V Jacquemin¹, M Chopin², G Pierron¹, O A Bernard³, J Ghysdael⁴, M-H Stern¹

Affiliations

¹ 1] Institut Curie, Centre de Recherche, Paris, France [2] INSERM U830, Paris, France.
² INSERM U940, Institut Universitaire d'Hématologie, Saint-Louis Hospital, Paris, France.
³ 1] INSERM U985, Institut Gustave Roussy, Villejuif, France [2] Université Paris-Sud, Orsay, France.
⁴ 1] Institut Curie, Centre Universitaire, Orsay, France [2] CNRS UMR 3306, Orsay, France [3] INSERM U1005, Orsay, France.

PMID: 24048415
DOI: 10.1038/leu.2013.271

No abstract available

Publication types

Letter

MeSH terms

Humans
Janus Kinase 1 / genetics*
Janus Kinase 3 / genetics*
Leukemia, Prolymphocytic, T-Cell / genetics*
Leukemia, Prolymphocytic, T-Cell / mortality
Mutation*

Substances

Janus Kinase 1
Janus Kinase 3